These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6788700)

  • 1. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
    Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
    Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.
    Martinez D; Callahan LT
    Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
    Galloway DR; Hedstrom RC; Pavlovskis OR
    Infect Immun; 1984 May; 44(2):262-7. PubMed ID: 6425217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.
    El-Zaim HS; Chopra AK; Peterson JW; Vasil ML; Heggers JP
    Infect Immun; 1998 Nov; 66(11):5551-4. PubMed ID: 9784572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics].
    Brodinova NS; Levdikova GA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.
    Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP
    Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M
    Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
    Safari Zanjani L; Shapouri R; Dezfulian M; Mahdavi M; Shafiee Ardestani M
    World J Microbiol Biotechnol; 2019 Jun; 35(6):94. PubMed ID: 31187291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound sepsis.
    Walker HL; McLeod CG; Leppla SH; Mason AD
    Infect Immun; 1979 Sep; 25(3):828-30. PubMed ID: 500188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
    Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
    J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
    Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
    Lydick E; Mclean AA; Woodhour AF; Callahan LT
    J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
    Gilleland HE; Gilleland LB; Fowler MR
    J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY; Tanimoto H
    Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.